 | |
| Clinical data | |
|---|---|
| Other names |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| PDB ligand | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C10H15N |
| Molar mass | 149.237 g·mol−1 |
| 3D model (JSmol) | |
| |
| Hazards | |
|---|---|
| GHS labelling:[1] | |
  | |
| Danger | |
| H314,H315,H319,H335 | |
| P260,P264,P264+P265,P271,P280,P301+P330+P331,P302+P352,P302+P361+P354,P304+P340,P305+P351+P338,P305+P354+P338,P316,P319,P321,P332+P317,P337+P317,P362+P364,P363,P403+P233,P405,P501 | |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
4-Phenylbutylamine, also known asbenzenebutanamine, is aphenylalkylamine or phenylbutylamine, consisting of abenzene ring in which one of thehydrogen atoms is substituted by a 4-aminobutyl group. It is aprimary amine and a member of the benzene class oforganic compounds. It it penetrateslipid bilayers in the cubicliquid-crystalline phase.[2]
serine protease inhibitor, It has been used in research as a testinhibitor to study the function of theenzymetrypsin; it is capable ofmimicking the side chain of theamino acidlysine orarginine, which allows it to bind to the active site of the enzymetrypsin.[1][3][4]
